製藥及生物製藥實驗室設備市場

藥理學和新治療藥物的開發對於維持人們的健康和長壽發揮著重要作用。從治療擦傷和瘀傷等基本疾病到治療複雜的癌症和罕見疾病，這個行業的重要性怎麼強調都不為過。然而，要創造理想的治療方法並不容易。必須識別該疾病，並且必須在早期階段開始調查以確定導致該疾病的原因。這是治療開發開始的地方，也是代謝途徑和蛋白質標靶等關鍵領域的研究開始的地方，它們的相互作用可能有助於改善疾病。隨後是生物和無機材料的發展。

這些藥物和治療方法在日益先進的平台上進行了有效性和安全性測試，為研究人員提供了更準確的回饋。然後，最好的候選藥物在臨床前研究、臨床試驗和轉化研究中進行測試，獲得監管部門的批准，並經過嚴格的QA/QC 流程，然後才能最終製造和銷售。為了獲得有關藥物性質、交互作用、作用機制、副作用、遞送方法、功效、製造一致性等的準確資料，必須以準確的方式進行測試。

所有藥物開發的中心都是進行研究和開發的製藥、生物技術和生物製藥公司。分析和生命科學設備的大部分需求來自於新療法上市的主要商業受益者公司。這些公司經常利用合約研究組織和學術機構等公共機構作為研發過程中的合作者。這些組織在當地監管框架內共同開發治療方法，以滿足世界人口日益成長的醫療保健需求。

該框架中的另一個重要合作夥伴是為快速發展的製藥/生物技術產業提供設備、耗材、設備和軟體解決方案的供應商網路。製藥/生物市場的未來成長將受到新的治療方式的推動，這些方式更加針對疾病，效果更好，研究和生產時間更短，並且更加依賴患者個體化治療。這將導致更高的價格以及特定的資本和基礎設施要求，導致更加依賴 CRO 和 CMO 來提供高通量篩選、自動化、專業知識和擴大資源。

本報告考察了製藥和生物製藥實驗室設備市場，詳細介紹了製藥/生物製藥領域使用的關鍵技術，涵蓋八類55項技術。未來五年的需求預測將依技術、領域、地區和處理類型進行呈現。它還著重於對藥物發現階段、治療重點以及治療藥物開發中面臨的挑戰的見解。

目次

簡介

• 報告背景
• 範圍和定義
• 製藥/生物產業的背景

市場需求

• 總體需求
• 生命科學設備
• 色譜法
• 質量分析
• 實驗室自動化
• 原子分光法
• 生物加工
• 成像
• 其他

頂級供應商

附錄

Pharmacology and the development of novel therapeutics is an important part of keeping people healthy and long living. From treating basic ailments like scrapes and bruises, to tackling complex cancers and rare diseases, the importance of this industry can't be overstated. However, creating an ideal therapeutic is not a strait forward process. An illness must be identified, and an early stage of research begins to determine what causes that illness. From here, the development of treatment begins, starting with the study of metabolic pathways, protein targets, and other key areas that may, when interacted with, help correct the ailment. The development of substances, both biological and inorganic, then proceeds. These drugs and treatments are tested for both efficacy and safety, on increasingly advanced platforms that offer more precise feedback for researchers. The best of these drug candidates are then tested in preclinical and clinical trials, translational research, and, after receiving regulatory approval, are finally manufactured and distributed, with rigorous QA/QC processes in place. Due to the nature of drugs and their interactions, mechanisms of action, side effects, the method of delivery, it's efficacy, consistency in manufacturing, and more all must be tested using precise methods to generate accurate data. The instruments covered in this report are the primary tools for conducting that research and form the critical infrastructure for pharmaceutical and biotherapeutic compounds. Further, innovations in the instruments, software controlling them, and analysis methods will further drive new biotherapeutics and drug formulations that are key to the success of the industry.

At the heart of all drug development are the pharmaceutical, biotech, and biopharmaceutical companies conducting research and development. They account for the majority of demand for analytical and life science instruments, as they are the main commercial benefactors of new therapeutics that are brought to market. These companies will often utilize contract research organizations and public sector organizations such as academia as collaborators in R&D processes. Together, these organizations work within regional regulatory frameworks to create therapeutics to meet the growing healthcare needs of the global population. Another key partner in this framework is network of suppliers that provide instruments, consumables, equipment, and software solutions to the fast-growing pharma/bio landscape. Future growth in the pharma/bio marketplace will be driven by new therapeutic modalities that are more specific to certain disease, delivered in better ways, with faster research and production timelines, and an increased reliance on personalization to patients. The resulting price tag and need for specific capital and infrastructure will further reliance on high throughput screening, automation, and reliance on CROs and CMOs that provide expertise and scale-up resources.

The SDi "Lab Instrumentation Markets for Pharmaceuticals & Biopharmaceuticals, 2024" report is an in-depth examination of the major technologies used in the pharma/bio sector, encompassing 55 techniques in 8 categories. The report examines historical growth and provides forecasts for demand over the next five years, segmented by technique, sector, region, and therapeutic type. This report focuses on delivering insights into phases of discovery, therapeutic focus, and the challenges being faced in therapeutics development.

Report Overview:

Technology categories included in this report are:

Top Vendors include:

Table of Contents

Introduction

• Report Background
• Scope & Definitions
• Background on the Pharma/Bio Sector

Market Demand

• Overall Demand
• Life Science Instrumentation
• Chromatography
• Mass Spectrometry
• Lab Automation
• Atomic Spectroscopy
• Bioprocessing
• Imaging
• Other Techniques

Appendix

• Recent & Upcoming Reports from SDi